Skip to main content
Frontier Biotechnologies Inc. (SHA:688221)
China flag China · Delayed Price · Currency is CNY
13.17
-0.45 (-3.30%)
At close: Nov 13, 2026

Frontier Biotechnologies Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
4,9336,7613,6563,7166,4656,688
Market Cap Growth
-24.35%84.94%-1.61%-42.53%-3.33%-3.43%
Enterprise Value
4,6306,4433,4423,0555,3915,318
Last Close Price
13.1718.059.769.9217.2618.59

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
13.7954.8028.2432.5276.29165.12
PB Ratio
5.137.713.202.773.873.65
P/TBV Ratio
5.789.023.693.344.574.26

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
12.9452.2226.5926.7463.61131.30

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.390.460.360.280.170.16
Debt / FCF Ratio
9.23-----
Net Debt / Equity Ratio
-0.31-0.35-0.39-0.42-0.58-0.65
Net Debt / EBITDA Ratio
7.041.301.871.862.734.19
Net Debt / FCF Ratio
-7.461.202.321.422.242.08
Asset Turnover
0.220.070.070.050.030.02
Inventory Turnover
1.621.581.911.421.471.91
Quick Ratio
4.352.212.812.654.643.76
Current Ratio
5.542.453.092.905.073.95
Return on Equity (ROE)
-3.69%-26.56%-16.21%-21.83%-20.38%-13.36%
Return on Assets (ROA)
-2.07%-9.59%-8.76%-9.45%-10.08%-7.95%
Return on Capital Employed (ROCE)
-3.80%-22.30%-19.50%-19.60%-18.70%-15.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-0.72%-3.96%-5.51%-8.85%-5.52%-3.89%
FCF Yield
0.82%-3.79%-5.23%-10.67%-6.64%-8.53%
Buyback Yield / Dilution
-1.84%0.17%0.24%-2.69%-0.79%-25.23%